Optigenex Inc.

OPGX

US6838863032

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 12:14:54 2023-10-20 pm EDT			5-day change	1st Jan Change
0.0003 ^USD	-99.97%		-.--%	-.--%

2017	Optigenex Inc. announced that it has received $0.63 million in funding	CI
2017	Optigenex Inc. announced a financing transaction	CI

Optigenex Inc. announced that it has received $0.63 million in funding

November 28, 2017

On November 29, 2017, Optigenex Inc. (OTCPK:OPGX) closed the transaction. The company has received $630,000 from six investors.

Latest news about Optigenex Inc.

Optigenex Inc. announced that it has received $0.63 million in funding	17-11-28	CI
Optigenex Inc. announced a financing transaction	17-11-06	CI
Optigenex Inc. Reports Positive Results from Double-Blind, Placebo Controlled Study of Onnit Labs Product, AlphaBrain with Ac-11	14-02-25	CI

Optigenex Inc. is an applied sciences company. The Company is focused on providing solutions for healthy age management. The Company is a provider of dietary supplements, skin care products and bulk ingredients. The Company formulates, licenses and markets its own natural cellular deoxyribonucleic acid (DNA) care ingredient known as ac-11. Its ac-11 is used in both dietary supplements and advanced cosmetics to repair skin damaged by overexposure to the sun, restore optimal cellular function, and promote healthy aging. The Companyâs technology helps the bodyâs natural ability to repair DNA; enhances the immune system by increasing the life cycle of white blood cells; repairs neural function damaged by overexposure to high decibel noise; helps to normalize the expression of NF-KB, thereby regulating the cellular response to systemic inflammation, and maintains telomere length and integrity during the process of cellular mitosis.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
OPTIGENEX INC.	-.--%	35
ELI LILLY AND COMPANY	+25.61%	672B
NOVO NORDISK A/S	+25.87%	570B
JOHNSON & JOHNSON	-5.24%	360B
MERCK & CO., INC.	+16.49%	321B
ABBVIE INC.	+8.28%	300B
ASTRAZENECA PLC	+7.09%	217B
ROCHE HOLDING AG	-9.12%	204B
NOVARTIS AG	+5.01%	199B
PFIZER, INC.	-8.75%	149B

Other Pharmaceuticals

Optigenex Inc.

Equities

OPGX

US6838863032

Pharmaceuticals

Optigenex Inc. announced that it has received $0.63 million in funding

Latest news about Optigenex Inc.

Chart Optigenex Inc.

Company Profile

Sector Other Pharmaceuticals